Consensus Statements Issued for Photoprotection for Skin of All Color
Consensus statements regarding sunscreen use and the associated risks from sun exposure have been developed by a panel of experts.
Melasma
Tranexamic and Glycolic Acid Peel for Melasma
A novel study assessed the efficacy, safety, and improvement in QoL index in patients with melasma treated with topical 5% tranexamic acid with 30% glycolic acid peel.
Insurance Claims and Prescriptions for Rosacea vs Melasma
Insurance coverage for topical treatments for rosacea vs melasma are investigated.
Oral Tranexamic Acid May Be a Treatment for Melasma in Patients With Concomitant Vitiligo
Treatment outcomes and adverse events of oral tranexamic acid (TA) in patients with vitiligo and melasma were assessed.
Synbiotics Supplement May Improve Melasma Severity
The effects of a synbiotics supplement (TS6) on improving melasma were investigated.
Chemical Peels for the Treatment of Melasma in Patients of Color
The study’s goal was to compare the clinical efficacy, safety, tolerability, and improvement in QOL index of three peeling agents for patients with melasma.
Promotion of UV Protection for Decreasing Melanoma Risk in Skin of Color Questioned
Data surrounding the association of UV exposure and risk for cutaneous melanoma in patients with skin of color was assessed.
UV Exposure and Melanoma Risk in Patients With Skin of Color
The pressing need to clarify risk factors and effective interventions for skin of color populations is underscored.
Single-Agent Chemical Peels for Melasma Treatment in Skin of Color
The efficacy and safety of single-agent chemical peels in patients with pigmented skin, was investigated via a systematic review and meta-analysis of the current literature.
Skin of Color Disproportionately Affected by Cutaneous Disorders
The racial and ethnic distribution of common dermatologic disorders seen at a US tertiary care center are characterized.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...